From the diversity of novel drugs to increasing scrutiny of pharma's claims, medical marketers face a broader array of challenges than ever before. And just as drug developers are attempting to accommodate each patient's unique needs, so, too, are marketers honing strategies to deliver targeted messages to patients, providers, and payers. Two drugs working their way toward approval each represent unique marketing challenges.
